题名

載藥微球肝動脈栓塞術簡介及護理

并列篇名

Drug-Eluting Bead Transcatheter Arterial Chemoembolization for Hepatic Neoplasms and Nursing Applications

DOI

10.6142/VGHN.33.2.134

作者

溫明寰(Ming-Huan Wen);林宜演(I-Yen Lin);張育綺(Yu-Chin Chang)

关键词

肝癌 ; 載藥微球 ; 載藥微球肝動脈栓塞術 ; hepatocellular carcinoma ; drug eluting beads ; transhepatic arterial embolization

期刊名称

榮總護理

卷期/出版年月

33卷2期(2016 / 06 / 01)

页次

134 - 140

内容语文

繁體中文

中文摘要

載藥微球肝動脈栓塞術,是使用載藥微球吸附化療藥物後,注射於肝動脈,結合化學治療與肝動脈栓塞術,簡化傳統肝癌之栓塞治療。藉由微球上化療藥物緩慢釋放,有效達到治療效果外,大幅降低化療藥物副作用,影響肝功能也較小。可延長病人存活時間,提高疾病控制率及較佳之生活品質。

英文摘要

Transhepatic arterial chemoembolization (TACE) with drug-eluting beads (DEBs) uses drugeluting microspheres to carry chemotherapy agents, and inject them into the hepatic artery. A combination of chemotherapy and transhepatic arterial chemoembolization can simplify traditional embolization therapy for hepatocellular carcinomas. The slow release of chemotherapy agents from the beads enhances treatment response, reduces the adverse effects of chemotherapy, and lowers the incidence of liver decompensation. Thus, TACE with DEBs prolongs patient survival, strengthens the disease remission rate, and provides a more favorable quality of life.

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. 衛生福利部(2015,6 月17 日).103 年死因統計結果分析. 取自http://www.mohw.gov.tw/news/531349778
  2. Bishay, V. L.,Maglione, K.,Khanna, R.,Lee, K. M.,Fischman, A. M.,Lookstein, R. A.,Kim, E.(2014).Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: Single-center review of safety and efficacy.Journal of Hepatocellular Carcinoma,1,187-193.
  3. Blümmel, J.,Reinhardt, S.,Schäfer, M.,Gilbert, C.,Sun, L.,Ren, J.(2012).Drug-eluting beads in the treatment of hepatocellular carcinoma and colorectal cancer metastases to the liver.European Oncology & Haematology,8(3),162-166.
  4. Huang, K.,Zhou, Q.,Wang, R.,Cheng, D.,Ma, Y.(2014).Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.Journal of Gastroenterology and Hepatology,29(5),920-925.
  5. Malagari, K.,Pomoni, M.,Moschouris, H.,Bouma, E. Koskinas, J.,Stefaniotou, A.,Kelekis, D.(2012).Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: Five-year survival analysis.Cardiovascular and Interventional Radiology,35(5),1119-1128.
  6. Malagari, K.,Pomoni, M.,Moschouris, H.,Kelekis, A.,Charokopakis, A.,Bouma, E.,Kelekis, D. A.(2014).Chemoembolization o f hepatocellular carcinoma with hepasphere 30-60 μm. safety and efficacy study.Cardiovascular and Interventional Radiology,37(1),165-175.
  7. Massmann, A.,Rodt, T.,Marquardt, S.,Seidei, R.,Thomas, K.,Wacker, F.,Sommer, C. M.(2015).Transarterial chemoembolization (TACE) for colorectal liver metastases - current status and critical review.Langenbecks Archives of Surgery,400(6),641-659.
  8. Seki, A.,Hori, S.,Kobayashi, K.,Narumiya, S .(2011).Transcatheter arterial chemoembolization with epirubicin loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients single-center experience.Cardiovascular and Interventional Radiology,34(3),557-565.
  9. She, H. L.,Burgmans, M. C.,Coenraadm, M.,Saraqueta, A. F.(2016).In vivo proof of superselective transarterial chemoembolization with 40 - μ m drug-eluting beads in a patient with hepatocellular carcinoma.Cardiovascular and Interventional Radiology,39(1),137-140.
  10. van Malenstein, H.,Maleux, G.,Vandecaveye, V.,Heye, S.,Laleman, W.,van Pelt, J.,Verslype, C.(2011).A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma.Onkologie,34(7),368-376.
  11. Wang, Y. J.,Baere, T. D.,Idee, J. M.,Ballet, S.(2015).Transcatheter embolization therapy in liver cancer: An update of clinical evidences.Chinese Journal of Cancer Research,27(2),96-121.
  12. 林錫銘(2012)。肝細胞癌診治的新進展。內科學誌,23(6),398-402。
  13. 金雪峰、陳慶財、宗在傳、許穎(2013)。載藥肝動脈栓塞微球的發展現況。中國新藥雜誌,22(19),2268-2273。
  14. 馮容芬、李惠玲、吳麗彬、周繡玲、袁素娟、胡月娟、尹裕君(2010)。成人內外科護理。台北:華杏。
  15. 黃敏瑢、王妍惠、宋雅雯(2012)。照顧一位肝癌患者接受動脈化學栓塞術後不良反應之護理經驗。腫瘤護理雜誌,12(1),45-57。
  16. 楊慧珍、陳美月(2009)。釔90 微球體─ 肝臟腫瘤選擇性體內放射線療法簡介及護理。榮總護理,26(3),222-227。
  17. 劉鐘軒、蔡正中、陳海雄(2013)。肝癌的診斷及治療最新發展。內科學誌,24(2),85- 94。
  18. 歐盛秋、陳祖毅、馬亦龍、蒙志斌(2014)。阿黴素載藥微球與傳統的碘化油經導管動脈化療栓塞術治療原發性肝癌療效的Meta 分析。中國介入影像與治療學,11(11),712-716。
  19. 賴慧倫、林淑媛(2007)。肝癌非手術治療與其護理。嘉基護理,7(1),1-7。
  20. 謝佩珍、鄭吉元、陳偉立(2012)。肝癌治療的進展。長庚藥學學報,19(3),1-5。
被引用次数
  1. 曾維莉,陳翊珺,陳怡燐,陳育臨,吳靜怡,吳湘芝,吳怡蓁,吳佩盈(2019)。提升經肝動脈灌注化療護理指導完整率。嘉基護理,19(1),27-39。
  2. 洪玉玲,宋聖芬,吳柳秀(2018)。協助一位初診斷肝癌病人首次接受經導管肝動脈化學栓塞術之護理經驗。腫瘤護理雜誌,18(1),107-118。